Results 131 to 140 of about 22,441 (303)
Multidimensional evaluation of four chaihu-shugan-san simulated decoction for use as placebo controls: a comparative study. [PDF]
Huang K +6 more
europepmc +1 more source
Objective Regeneration and expansion of Treg by low‐dose interleukin‐2 (IL‐2) therapy is considered a potential treatment strategy for a wide range of autoimmune diseases. To provide a pathophysiologically‐based rationale for low‐dose IL‐2 therapy, we investigated whether reversible defects in the Treg–IL‐2 axis emerge in inflammatory myopathies ...
Justus Ohmes +10 more
wiley +1 more source
Methodological considerations for designing and conducting open-label placebo trials. [PDF]
Hartmann H +13 more
europepmc +1 more source
Objective To assess guselkumab + golimumab combination therapy versus guselkumab monotherapy in participants with active psoriatic arthritis (PsA) and inadequate response to tumor necrosis factor inhibitors (TNFi‐IR). Methods Adults with active TNFi‐IR PsA (three or more tender/swollen joints) were randomized (2:1) to subcutaneous guselkumab (100 mg) +
Jose U. Scher +12 more
wiley +1 more source
Open-label placebos reduce hair cortisol concentrations and psychological distress - a randomized controlled trial. [PDF]
Liedtke C, Schaefer M, Enge S.
europepmc +1 more source
Placebos, Active Placebos, and Clinical Trials [PDF]
openaire +2 more sources
Objective The purpose of this study was to determine the benefit of a behaviorally designed incentive program and glucocorticoid injections in reducing symptoms and promoting physical activity in patients with knee osteoarthritis (KOA). Methods This was a pragmatic, multisite, factorially designed, blinded, randomized clinical trial.
Joshua F. Baker +17 more
wiley +1 more source
Effects of an open-label placebo on divergent thinking performance. [PDF]
Marlies S +4 more
europepmc +1 more source
Disease classification criteria and response criteria are important tools in the conduct of observational studies and clinical trials for rheumatic diseases. This paper updates methodologic guidance for classification and response criteria funded, developed and/or endorsed by the American College of Rheumatology (ACR), incorporating contemporary ...
Sindhu R. Johnson +4 more
wiley +1 more source

